 | • レポートコード：MRC2012A4195 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、グリコーゲンシンターゼキナーゼ3ベータの世界市場を広く調査・分析し、今後の市場展望をまとめております。グリコーゲンシンターゼキナーゼ3ベータの種類別市場規模（AP-001、AP-1、DM-204、Neu-120、その他）、用途別市場規模（筋骨格系障害、肺がん、ジスキネジア、メンケス病、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Mitsubishi Tanabe Pharma Corp、DiaMedica Therapeutics Inc、Neurim Pharmaceuticals Ltd、AMO Pharma Ltd、Actuate Therapeutics Inc、Jeil Pharmaceutical Co Ltd、Angelini Group、 ・地域別グローバル市場分析 2015年-2020年 ・グリコーゲンシンターゼキナーゼ3ベータの北米市場（アメリカ、カナダ、メキシコ） ・グリコーゲンシンターゼキナーゼ3ベータのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・グリコーゲンシンターゼキナーゼ3ベータのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・グリコーゲンシンターゼキナーゼ3ベータの南米市場（ブラジル、アルゼンチン） ・グリコーゲンシンターゼキナーゼ3ベータの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：AP-001、AP-1、DM-204、Neu-120、その他 ・用途別分析：筋骨格系障害、肺がん、ジスキネジア、メンケス病、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Glycogen Synthase Kinase 3 Beta market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Glycogen Synthase Kinase 3 Beta market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Glycogen Synthase Kinase 3 Beta market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Glycogen Synthase Kinase 3 Beta market has been segmented into
AP-001
AP-1
DM-204
Neu-120
Others
By Application, Glycogen Synthase Kinase 3 Beta has been segmented into:
Musculoskeletal Disorder
Lung Cancer
Dyskinesia
Menkes Disease
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Glycogen Synthase Kinase 3 Beta market presented in the report. This section sheds light on the sales growth of different regional and country-level Glycogen Synthase Kinase 3 Beta markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Glycogen Synthase Kinase 3 Beta market.
The report offers in-depth assessment of the growth and other aspects of the Glycogen Synthase Kinase 3 Beta market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Glycogen Synthase Kinase 3 Beta Market Share Analysis
Glycogen Synthase Kinase 3 Beta competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Glycogen Synthase Kinase 3 Beta sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Glycogen Synthase Kinase 3 Beta sales, revenue and market share for each player covered in this report.
The major players covered in Glycogen Synthase Kinase 3 Beta are:
Mitsubishi Tanabe Pharma Corp
DiaMedica Therapeutics Inc
Neurim Pharmaceuticals Ltd
AMO Pharma Ltd
Actuate Therapeutics Inc
Jeil Pharmaceutical Co Ltd
Angelini Group
Among other players domestic and global, Glycogen Synthase Kinase 3 Beta market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glycogen Synthase Kinase 3 Beta product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Glycogen Synthase Kinase 3 Beta, with price, sales, revenue and global market share of Glycogen Synthase Kinase 3 Beta in 2018 and 2019.
Chapter 3, the Glycogen Synthase Kinase 3 Beta competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glycogen Synthase Kinase 3 Beta breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Glycogen Synthase Kinase 3 Beta market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Glycogen Synthase Kinase 3 Beta sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Glycogen Synthase Kinase 3 Beta Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Glycogen Synthase Kinase 3 Beta Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 AP-001
1.2.3 AP-1
1.2.4 DM-204
1.2.5 Neu-120
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Glycogen Synthase Kinase 3 Beta Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Musculoskeletal Disorder
1.3.3 Lung Cancer
1.3.4 Dyskinesia
1.3.5 Menkes Disease
1.3.6 Others
1.4 Overview of Global Glycogen Synthase Kinase 3 Beta Market
1.4.1 Global Glycogen Synthase Kinase 3 Beta Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Mitsubishi Tanabe Pharma Corp
2.1.1 Mitsubishi Tanabe Pharma Corp Details
2.1.2 Mitsubishi Tanabe Pharma Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Mitsubishi Tanabe Pharma Corp SWOT Analysis
2.1.4 Mitsubishi Tanabe Pharma Corp Product and Services
2.1.5 Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 DiaMedica Therapeutics Inc
2.2.1 DiaMedica Therapeutics Inc Details
2.2.2 DiaMedica Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 DiaMedica Therapeutics Inc SWOT Analysis
2.2.4 DiaMedica Therapeutics Inc Product and Services
2.2.5 DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Neurim Pharmaceuticals Ltd
2.3.1 Neurim Pharmaceuticals Ltd Details
2.3.2 Neurim Pharmaceuticals Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Neurim Pharmaceuticals Ltd SWOT Analysis
2.3.4 Neurim Pharmaceuticals Ltd Product and Services
2.3.5 Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 AMO Pharma Ltd
2.4.1 AMO Pharma Ltd Details
2.4.2 AMO Pharma Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AMO Pharma Ltd SWOT Analysis
2.4.4 AMO Pharma Ltd Product and Services
2.4.5 AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Actuate Therapeutics Inc
2.5.1 Actuate Therapeutics Inc Details
2.5.2 Actuate Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Actuate Therapeutics Inc SWOT Analysis
2.5.4 Actuate Therapeutics Inc Product and Services
2.5.5 Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Jeil Pharmaceutical Co Ltd
2.6.1 Jeil Pharmaceutical Co Ltd Details
2.6.2 Jeil Pharmaceutical Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Jeil Pharmaceutical Co Ltd SWOT Analysis
2.6.4 Jeil Pharmaceutical Co Ltd Product and Services
2.6.5 Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Angelini Group
2.7.1 Angelini Group Details
2.7.2 Angelini Group Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Angelini Group SWOT Analysis
2.7.4 Angelini Group Product and Services
2.7.5 Angelini Group Glycogen Synthase Kinase 3 Beta Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Glycogen Synthase Kinase 3 Beta Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Glycogen Synthase Kinase 3 Beta Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Glycogen Synthase Kinase 3 Beta Manufacturer Market Share in 2019
3.3.2 Top 6 Glycogen Synthase Kinase 3 Beta Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Glycogen Synthase Kinase 3 Beta Sales, Revenue and Market Share by Regions
4.1.1 Global Glycogen Synthase Kinase 3 Beta Sales and Market Share by Regions (2015-2020)
4.1.2 Global Glycogen Synthase Kinase 3 Beta Revenue and Market Share by Regions (2015-2020)
4.2 North America Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
4.3 Europe Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
4.5 South America Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Glycogen Synthase Kinase 3 Beta Sales, Revenue and Market Share by Country
5.1.1 North America Glycogen Synthase Kinase 3 Beta Sales and Market Share by Country (2015-2020)
5.1.2 North America Glycogen Synthase Kinase 3 Beta Revenue and Market Share by Country (2015-2020)
5.2 United States Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
5.3 Canada Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
5.4 Mexico Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Glycogen Synthase Kinase 3 Beta Sales, Revenue and Market Share by Country
6.1.1 Europe Glycogen Synthase Kinase 3 Beta Sales and Market Share by Country (2015-2020)
6.1.2 Europe Glycogen Synthase Kinase 3 Beta Revenue and Market Share by Country (2015-2020)
6.2 Germany Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
6.3 UK Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
6.4 France Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
6.5 Russia Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
6.6 Italy Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Glycogen Synthase Kinase 3 Beta Revenue and Market Share by Regions (2015-2020)
7.2 China Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
7.3 Japan Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
7.4 Korea Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
7.5 India Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
7.7 Australia Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Glycogen Synthase Kinase 3 Beta Sales, Revenue and Market Share by Country
8.1.1 South America Glycogen Synthase Kinase 3 Beta Sales and Market Share by Country (2015-2020)
8.1.2 South America Glycogen Synthase Kinase 3 Beta Revenue and Market Share by Country (2015-2020)
8.2 Brazil Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
8.3 Argentina Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Glycogen Synthase Kinase 3 Beta Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
9.3 Turkey Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
9.4 Egypt Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
9.5 South Africa Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Glycogen Synthase Kinase 3 Beta Sales and Market Share by Type (2015-2020)
10.2 Global Glycogen Synthase Kinase 3 Beta Revenue and Market Share by Type (2015-2020)
10.3 Global Glycogen Synthase Kinase 3 Beta Price by Type (2015-2020)
11 Global Glycogen Synthase Kinase 3 Beta Market Segment by Application
11.1 Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Application (2015-2020)
11.2 Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Application (2015-2020)
11.3 Global Glycogen Synthase Kinase 3 Beta Price by Application (2015-2020)
12 Market Forecast
12.1 Global Glycogen Synthase Kinase 3 Beta Sales, Revenue and Growth Rate (2021-2025)
12.2 Glycogen Synthase Kinase 3 Beta Market Forecast by Regions (2021-2025)
12.2.1 North America Glycogen Synthase Kinase 3 Beta Market Forecast (2021-2025)
12.2.2 Europe Glycogen Synthase Kinase 3 Beta Market Forecast (2021-2025)
12.2.3 Asia-Pacific Glycogen Synthase Kinase 3 Beta Market Forecast (2021-2025)
12.2.4 South America Glycogen Synthase Kinase 3 Beta Market Forecast (2021-2025)
12.2.5 Middle East & Africa Glycogen Synthase Kinase 3 Beta Market Forecast (2021-2025)
12.3 Glycogen Synthase Kinase 3 Beta Market Forecast by Type (2021-2025)
12.3.1 Global Glycogen Synthase Kinase 3 Beta Sales Forecast by Type (2021-2025)
12.3.2 Global Glycogen Synthase Kinase 3 Beta Market Share Forecast by Type (2021-2025)
12.4 Glycogen Synthase Kinase 3 Beta Market Forecast by Application (2021-2025)
12.4.1 Global Glycogen Synthase Kinase 3 Beta Sales Forecast by Application (2021-2025)
12.4.2 Global Glycogen Synthase Kinase 3 Beta Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Glycogen Synthase Kinase 3 Beta Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Glycogen Synthase Kinase 3 Beta by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Glycogen Synthase Kinase 3 Beta Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Mitsubishi Tanabe Pharma Corp Basic Information, Manufacturing Base and Competitors
Table 8. Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Major Business
Table 9. Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Total Revenue (USD Million) (2017-2018)
Table 10. Mitsubishi Tanabe Pharma Corp SWOT Analysis
Table 11. Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Product and Services
Table 12. Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. DiaMedica Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 14. DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Major Business
Table 15. DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Total Revenue (USD Million) (2017-2018)
Table 16. DiaMedica Therapeutics Inc SWOT Analysis
Table 17. DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Product and Services
Table 18. DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Neurim Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 20. Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Major Business
Table 21. Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Total Revenue (USD Million) (2017-2018)
Table 22. Neurim Pharmaceuticals Ltd SWOT Analysis
Table 23. Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Product and Services
Table 24. Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. AMO Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 26. AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Major Business
Table 27. AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Total Revenue (USD Million) (2017-2018)
Table 28. AMO Pharma Ltd SWOT Analysis
Table 29. AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Product and Services
Table 30. AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Actuate Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 32. Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Major Business
Table 33. Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Total Revenue (USD Million) (2017-2018)
Table 34. Actuate Therapeutics Inc SWOT Analysis
Table 35. Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Product and Services
Table 36. Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Jeil Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 38. Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Major Business
Table 39. Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Total Revenue (USD Million) (2017-2018)
Table 40. Jeil Pharmaceutical Co Ltd SWOT Analysis
Table 41. Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Product and Services
Table 42. Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Angelini Group Basic Information, Manufacturing Base and Competitors
Table 44. Angelini Group Glycogen Synthase Kinase 3 Beta Major Business
Table 45. Angelini Group Glycogen Synthase Kinase 3 Beta Total Revenue (USD Million) (2017-2018)
Table 46. Angelini Group SWOT Analysis
Table 47. Angelini Group Glycogen Synthase Kinase 3 Beta Product and Services
Table 48. Angelini Group Glycogen Synthase Kinase 3 Beta Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Glycogen Synthase Kinase 3 Beta Sales by Manufacturer (2018-2019) (K Pcs)
Table 50. Global Glycogen Synthase Kinase 3 Beta Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Glycogen Synthase Kinase 3 Beta Sales by Regions (2015-2020) (K Pcs)
Table 52. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Regions (2015-2020)
Table 53. Global Glycogen Synthase Kinase 3 Beta Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Glycogen Synthase Kinase 3 Beta Sales by Countries (2015-2020) (K Pcs)
Table 55. North America Glycogen Synthase Kinase 3 Beta Sales Market Share by Countries (2015-2020)
Table 56. North America Glycogen Synthase Kinase 3 Beta Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Glycogen Synthase Kinase 3 Beta Revenue Market Share by Countries (2015-2020)
Table 58. Europe Glycogen Synthase Kinase 3 Beta Sales by Countries (2015-2020) (K Pcs)
Table 59. Europe Glycogen Synthase Kinase 3 Beta Sales Market Share by Countries (2015-2020)
Table 60. Europe Glycogen Synthase Kinase 3 Beta Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales by Regions (2015-2020) (K Pcs)
Table 62. Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Glycogen Synthase Kinase 3 Beta Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Glycogen Synthase Kinase 3 Beta Sales by Countries (2015-2020) (K Pcs)
Table 65. South America Glycogen Synthase Kinase 3 Beta Sales Market Share by Countries (2015-2020)
Table 66. South America Glycogen Synthase Kinase 3 Beta Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Glycogen Synthase Kinase 3 Beta Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales by Countries (2015-2020) (K Pcs)
Table 69. Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Glycogen Synthase Kinase 3 Beta Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Glycogen Synthase Kinase 3 Beta Revenue Market Share by Countries (2015-2020)
Table 72. Global Glycogen Synthase Kinase 3 Beta Sales by Type (2015-2020) (K Pcs)
Table 73. Global Glycogen Synthase Kinase 3 Beta Sales Share by Type (2015-2020)
Table 74. Global Glycogen Synthase Kinase 3 Beta Revenue by Type (2015-2020) (USD Million)
Table 75. Global Glycogen Synthase Kinase 3 Beta Revenue Share by Type (2015-2020)
Table 76. Global Glycogen Synthase Kinase 3 Beta Sales by Application (2015-2020) (K Pcs)
Table 77. Global Glycogen Synthase Kinase 3 Beta Sales Share by Application (2015-2020)
Table 78. Global Glycogen Synthase Kinase 3 Beta Sales Forecast by Regions (2021-2025) (K Pcs)
Table 79. Global Glycogen Synthase Kinase 3 Beta Market Share Forecast by Regions (2021-2025)
Table 80. Global Glycogen Synthase Kinase 3 Beta Sales Forecast by Type (2021-2025) (K Pcs)
Table 81. Global Glycogen Synthase Kinase 3 Beta Market Share Forecast by Type (2021-2025)
Table 82. Global Glycogen Synthase Kinase 3 Beta Sales Forecast by Application (2021-2025)
Table 83. Global Glycogen Synthase Kinase 3 Beta Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Glycogen Synthase Kinase 3 Beta Picture
Figure 2. Global Sales Market Share of Glycogen Synthase Kinase 3 Beta by Type in 2019
Figure 3. AP-001 Picture
Figure 4. AP-1 Picture
Figure 5. DM-204 Picture
Figure 6. Neu-120 Picture
Figure 7. Others Picture
Figure 8. Glycogen Synthase Kinase 3 Beta Sales Market Share by Application in 2018
Figure 9. Musculoskeletal Disorder Picture
Figure 10. Lung Cancer Picture
Figure 11. Dyskinesia Picture
Figure 12. Menkes Disease Picture
Figure 13. Others Picture
Figure 14. Global Glycogen Synthase Kinase 3 Beta Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Glycogen Synthase Kinase 3 Beta Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Glycogen Synthase Kinase 3 Beta Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Glycogen Synthase Kinase 3 Beta Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Glycogen Synthase Kinase 3 Beta Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Glycogen Synthase Kinase 3 Beta Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Glycogen Synthase Kinase 3 Beta Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Glycogen Synthase Kinase 3 Beta Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Glycogen Synthase Kinase 3 Beta Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Glycogen Synthase Kinase 3 Beta Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Glycogen Synthase Kinase 3 Beta Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Glycogen Synthase Kinase 3 Beta Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Glycogen Synthase Kinase 3 Beta Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Glycogen Synthase Kinase 3 Beta Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Glycogen Synthase Kinase 3 Beta Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Glycogen Synthase Kinase 3 Beta Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Glycogen Synthase Kinase 3 Beta Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Glycogen Synthase Kinase 3 Beta Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Glycogen Synthase Kinase 3 Beta Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Glycogen Synthase Kinase 3 Beta Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Manufacturer in 2019
Figure 35. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Glycogen Synthase Kinase 3 Beta Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Glycogen Synthase Kinase 3 Beta Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020) (K Pcs)
Figure 40. Global Glycogen Synthase Kinase 3 Beta Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Regions (2015-2020)
Figure 42. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Regions in 2018
Figure 43. North America Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
Figure 44. Europe Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
Figure 46. South America Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020)
Figure 48. North America Glycogen Synthase Kinase 3 Beta Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Glycogen Synthase Kinase 3 Beta Sales Market Share by Countries (2015-2020)
Figure 50. North America Glycogen Synthase Kinase 3 Beta Sales Market Share by Countries in 2018
Figure 51. North America Glycogen Synthase Kinase 3 Beta Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Glycogen Synthase Kinase 3 Beta Revenue Market Share by Countries in 2018
Figure 53. United States Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Canada Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Mexico Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Europe Glycogen Synthase Kinase 3 Beta Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Glycogen Synthase Kinase 3 Beta Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Glycogen Synthase Kinase 3 Beta Revenue Market Share by Countries in 2019
Figure 59. Germany Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. UK Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. France Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Asia-Pacific Glycogen Synthase Kinase 3 Beta Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Glycogen Synthase Kinase 3 Beta Revenue Market Share by Regions 2019
Figure 67. China Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Korea Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. India Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Southeast Asia Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. South America Glycogen Synthase Kinase 3 Beta Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Glycogen Synthase Kinase 3 Beta Sales Market Share by Countries in 2019
Figure 74. South America Glycogen Synthase Kinase 3 Beta Revenue Market Share by Countries in 2019
Figure 75. Brazil Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Argentina Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Middle East and Africa Glycogen Synthase Kinase 3 Beta Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Glycogen Synthase Kinase 3 Beta Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Glycogen Synthase Kinase 3 Beta Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Egypt Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Turkey Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. South Africa Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Global Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2025) (K Pcs)
Figure 86. Global Glycogen Synthase Kinase 3 Beta Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Glycogen Synthase Kinase 3 Beta Market Forecast (2021-2025) (K Pcs)
Figure 88. Europe Sales Glycogen Synthase Kinase 3 Beta Market Forecast (2021-2025) (K Pcs)
Figure 89. Asia-Pacific Sales Glycogen Synthase Kinase 3 Beta Market Forecast (2021-2025) (K Pcs)
Figure 90. South America Sales Glycogen Synthase Kinase 3 Beta Market Forecast (2021-2025) (K Pcs)
Figure 91. Middle East & Africa Sales Glycogen Synthase Kinase 3 Beta Market Forecast (2021-2025) (K Pcs)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
グリコーゲンシンターゼキナーゼ3ベータの世界市場（～2026年） Market Analysis and Insights: Global Glycogen Synthase Kinase 3 Beta Market The global Glycogen Synthase Kinase 3 Beta market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Glycogen Synthase Kinase 3 Beta Scope and Market Si…- 核因子カッパBキナーゼサブユニットベータ阻害剤の世界市場（～2026年） Market Analysis and Insights: Global Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta Market The global Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Inh…
- RACベータセリン/スレオニンプロテインキナーゼの世界市場（～2026年） Market Analysis and Insights: Global RAC Beta Serine/Threonine Protein Kinase Market The global RAC Beta Serine/Threonine Protein Kinase market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global RAC Beta Serine/Threonine Protein…
- ホスファチジルイノシトール4,5ビスホスフェート3キナーゼ触媒サブユニットベータアイソフォームの世界市場（～2026年） Market Analysis and Insights: Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market The global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at…
- 一酸化窒素シンターゼ脳の世界市場（～2026年） Market Analysis and Insights: Global Nitric Oxide Synthase Brain Market The global Nitric Oxide Synthase Brain market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Nitric Oxide Synthase Brain Scope and Market Size Nitric Ox…